| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |